WHAT IS NANOXRAY ?
Radiotherapy is a local treatment ‘par excellence’ that can change the life-threatening outcome of several cancers, either alone or in combination with other therapeutic approaches. Radiotherapy use ionizing radiation to destroy cancer cells by blocking their capacity to proliferate. The radiation interacts with water molecules in the cell whichin the end generates free radicals killing the cell.
Today, many cancer patients do not receive doses sufficient for tumor destruction, respond insufficiently or not at all to treatments, or even develop resistance to these treatments. Radiotherapy on the opposite is known to be an efficacious – the higher the delivered dose, the better the response. In order to obtain greater radiotherapy efficacy without changing the standard treatment procedures, the dose delivered to the tumor must be increased without increasing its effect on healthy tissues.
The company has developed a disruptive approach for the local treatment of cancer. NanoXray nanoparticles can overcome one of the greatest limitations of radiotherapy: the impossibility of delivering a radiation dose sufficient to reliably destroy the tumor only. At present, this is not feasible because of side effects in the surrounding healthy tissues.
NanoXray nanoparticles were designed to increase the dose and efficacy of radiotherapy inside the tumor without causing additional damage to healthy tissues. Their average size is 50 nm, enabling them to enter and act on cancer cells. They are composed of an inorganic core of crystallized hafnium oxide. The high electron density of this material is in fact the most important feature, enabling a strong interaction with X-rays.
WHAT IS NANOXRAY ?
Radiotherapy is a local treatment ‘par excellence’ that can change the life-threatening outcome of several cancers, either alone or in combination with other therapeutic approaches. Radiotherapy use ionizing radiation to destroy cancer cells by blocking their capacity to proliferate. The radiation interacts with water molecules in the cell whichin the end generates free radicals killing the cell.
Today, many cancer patients do not receive doses sufficient for tumor destruction, respond insufficiently or not at all to treatments, or even develop resistance to these treatments. Radiotherapy on the opposite is known to be an efficacious – the higher the delivered dose, the better the response. In order to obtain greater radiotherapy efficacy without changing the standard treatment procedures, the dose delivered to the tumor must be increased without increasing its effect on healthy tissues.
The company has developed a disruptive approach for the local treatment of cancer. NanoXray nanoparticles can overcome one of the greatest limitations of radiotherapy: the impossibility of delivering a radiation dose sufficient to reliably destroy the tumor only. At present, this is not feasible because of side effects in the surrounding healthy tissues.
NanoXray nanoparticles were designed to increase the dose and efficacy of radiotherapy inside the tumor without causing additional damage to healthy tissues. Their average size is 50 nm, enabling them to enter and act on cancer cells. They are composed of an inorganic core of crystallized hafnium oxide. The high electron density of this material is in fact the most important feature, enabling a strong interaction with X-rays.
การแปล กรุณารอสักครู่..